Subsequently, we explored variations in mRNA expression of the LPL gene concerning histological staging, gender, lymph node metastasis, TP53 mutations, and methylation through the UALCAN database. The gene discussed is LPL; the disease is metastatic malignant neoplasm in the lymph nodes.